Prothena Corp Plc (PRTA) - Financial Analysis Review

Summary

Prothena Corp Plc (Prothena) is a late stage clinical biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company concentrates on monoclonal antibodies directed specifically at disease-causing proteins. Its pipeline products comprise PRX002, indicated for the treatment of Parkinsons disease; NEOD001, indicated for the treatment of primary systemic amyloidosis; PRX003, indicated for the treatment of psoriasis and other inflammatory diseases. The company provides research and development services to other pharmaceutical and biotechnology companies.

GlobalData's Prothena Corp Plc (PRTA) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Prothena Corp Plc Key Recent Developments:

Nov 01,2016: Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update
Oct 03,2016: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director
Sep 06,2016: Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
Aug 02,2016: Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update
May 19,2016: Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns